Sacituzumab Tirumotecan 用于卵巢癌患者的临床试验 (MK-2870-021) (TroFuse-021)
一项针对新诊断晚期HRD阴性卵巢癌患者在一线铂类化疗后使用Sacituzumab Tirumotecan(Sac-TMT,MK-2870)联合或不联合贝伐珠单抗维持治疗与标准治疗的3期、随机、开放标签、多中心研究(TroFuse-021/ENGOTov85/GOG-3102)
Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as much of the cancer as possible. After surgery, people may receive chemotherapy. After chemotherapy, standard care options may include:
- Maintenance treatment, which is used after another therapy to keep the cancer from growing, spreading, or coming back. Bevacizumab is a targeted therapy used as standard maintenance treatment. Targeted therapy works to control how specific types of cancer cells grow and spread.
- Observation, which is watching to see if cancer grows or worsens
The study medicine, sacituzumab tirumotecan (also called sac-TMT), is a targeted therapy. The goal of this study is to learn if people who receive sac-TMT maintenance treatment with or without bevacizumab live longer without the cancer getting worse than people who receive standard care.
研究概览
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Toll Free Number
- 电话号码:1-888-577-8839
- 邮箱:Trialsites@msd.com
学习地点
-
-
Capital Region
-
Herlev、Capital Region、丹麦、2730
- 招聘中
- Herlev Hospital ( Site 0902)
-
接触:
- Study Coordinator
- 电话号码:+4538689255
-
-
North Denmark
-
Aalborg、North Denmark、丹麦、9000
- 招聘中
- Aalborg Universitetshospital ( Site 0901)
-
接触:
- Study Coordinator
- 电话号码:+4597660000
-
Aarhus、North Denmark、丹麦、8200
- 招聘中
- Aarhus Universitetshospital, Skejby ( Site 0903)
-
接触:
- Study Coordinator
- 电话号码:+4578450000
-
-
Region Syddanmark
-
Odense、Region Syddanmark、丹麦、9000
- 招聘中
- Odense Universitets Hospital ( Site 0904)
-
接触:
- Study Coordinator
- 电话号码:+4523604974
-
-
-
-
-
Haifa、以色列、3109601
- 招聘中
- Rambam Health Care Campus ( Site 1422)
-
接触:
- Study Coordinator
- 电话号码:+97247772688
-
Holon、以色列、5810001
- 招聘中
- Edith Wolfson Medical Center ( Site 1423)
-
接触:
- Study Coordinator
- 电话号码:+97235028211
-
Ramat Gan、以色列、5265601
- 招聘中
- Sheba Medical Center ( Site 1421)
-
接触:
- Study Coordinator
- 电话号码:+97235303030
-
-
-
-
Quebec
-
Chicoutimi、Quebec、加拿大、G7H 5H6
- 招聘中
- CIUSSS - Saguenay-Lac-Saint-Jean ( Site 0519)
-
接触:
- Study Coordinator
- 电话号码:418 541-1000
-
Montreal、Quebec、加拿大、H4A 3J1
- 招聘中
- McGill University Health Centre ( Site 0516)
-
接触:
- Study Coordinator
- 电话号码:514-934-1934 x31975
-
Montreal、Quebec、加拿大、H2X 3H8
- 招聘中
- Centre Hospitalier de l'Université de Montréal ( Site 0518)
-
接触:
- Study Coordinator
- 电话号码:514-890-8000
-
-
-
-
-
Budapest、匈牙利、1122
- 招聘中
- Országos Onkológiai Intézet-Ngyógyászat ( Site 3913)
-
接触:
- Study Coordinator
- 电话号码:+3612248600
-
Budapest、匈牙利、1088
- 招聘中
- Semmelweis Egyetem I. Szamu Szuleszeti es Nogyogyaszati Klinika ( Site 3915)
-
接触:
- Study Coordinator
- 电话号码:+36 1 266 0473
-
Debrecen、匈牙利、4032
- 招聘中
- Debreceni Egyetem Klinikai Kozpont-Szülészeti és Nőgyógyászati Klinika ( Site 3912)
-
接触:
- Study Coordinator
- 电话号码:0652255705
-
-
Bács-Kiskun county
-
Kecskemét、Bács-Kiskun county、匈牙利、6000
- 招聘中
- Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 3910)
-
接触:
- Study Coordinator
- 电话号码:+3676516719
-
-
Győr-Moson-Sopron
-
Győr、Győr-Moson-Sopron、匈牙利、9024
- 招聘中
- Petz Aladar Egyetemi Oktato Korhaz-Onkológiai Osztály ( Site 3911)
-
接触:
- Study Coordinator
- 电话号码:+3696418244
-
-
-
-
-
Taichung、台湾、40705
- 招聘中
- Taichung Veterans General Hospital ( Site 2603)
-
接触:
- Study Coordinator
- 电话号码:886-4-23592525x5822
-
Tainan、台湾、704302
- 招聘中
- National Cheng Kung University Hospital ( Site 2602)
-
接触:
- Study Coordinator
- 电话号码:+8862353535
-
Taipei、台湾、104
- 招聘中
- Mackay Memorial Hospital ( Site 2604)
-
接触:
- Study Coordinator
- 电话号码:+886225433535
-
Taipei、台湾、10002
- 招聘中
- National Taiwan University Hospital ( Site 2601)
-
接触:
- Study Coordinator
- 电话号码:886-223123456x271563
-
Taoyuan、台湾、333
- 招聘中
- Linkou Chang Gung Memorial Hospital ( Site 2605)
-
接触:
- Study Coordinator
- 电话号码:886-33281200x8258
-
-
-
-
Antioquia
-
Medellín、Antioquia、哥伦比亚、050030
- 招聘中
- Fundacion Colombiana de Cancerología Clinica Vida ( Site 0803)
-
接触:
- Study Coordinator
- 电话号码:+576044480016
-
-
Bogota D.C.
-
Bogotá、Bogota D.C.、哥伦比亚、110131
- 招聘中
- FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0801)
-
接触:
- Study Coordinator
- 电话号码:+573044921963
-
-
Cesar Department
-
Valledupar、Cesar Department、哥伦比亚、200001
- 招聘中
- Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0802)
-
接触:
- Study Coordinator
- 电话号码:605 5804141
-
-
Cundinamarca
-
Bogota、Cundinamarca、哥伦比亚、111151
- 招聘中
- Instituto Nacional De Cancerologia ( Site 0808)
-
接触:
- Study Coordinator
- 电话号码:+5714320160
-
-
Risaralda Department
-
Pereira、Risaralda Department、哥伦比亚、660001
- 招聘中
- Oncólogos del Occidente S.A.S. ( Site 0806)
-
接触:
- Study Coordinator
- 电话号码:+573002558656
-
-
-
-
State of Vienna
-
Vienna、State of Vienna、奥地利、1090
- 招聘中
- Medizinische Universitat Wien ( Site 0102)
-
接触:
- Study Coordinator
- 电话号码:+43 1 4040061030
-
-
Tyrol
-
Innsbruck、Tyrol、奥地利、6020
- 招聘中
- Medizinische Universitaet Innsbruck-Univ.-Klinik f. Gynäkologie und Geburtshilfe ( Site 0101)
-
接触:
- Study Coordinator
- 电话号码:+4351250483105
-
-
Upper Austria
-
Linz、Upper Austria、奥地利、4021
- 招聘中
- Keppler Universitatsklinikum ( Site 0103)
-
接触:
- Study Coordinator
- 电话号码:+43 5 7680 83 78899
-
-
-
-
-
Rio de Janeiro、巴西、20220-410
- 招聘中
- Instituto Nacional de Câncer - INCA ( Site 0418)
-
接触:
- Study Coordinator
- 电话号码:+552132072985
-
São Paulo、巴西、04014-002
- 招聘中
- IBCC - Núcleo de Pesquisa e Ensino ( Site 0416)
-
接触:
- Study Coordinator
- 电话号码:+551144500360
-
-
Estado de Bahia
-
Salvador、Estado de Bahia、巴西、41680-430
- 招聘中
- Obras Sociais Irma Dulce ( Site 0427)
-
接触:
- Study Coordinator
- 电话号码:+55 71 3310-1978
-
-
Rio Grande do Norte
-
Natal、Rio Grande do Norte、巴西、59062-000
- 招聘中
- Liga Norte Riograndense Contra o Cancer ( Site 0417)
-
接触:
- Study Coordinator
- 电话号码:+558440095595
-
-
Rio Grande do Sul
-
Porto Alegre、Rio Grande do Sul、巴西、90610000
- 招聘中
- Hospital São Lucas da PUCRS ( Site 0415)
-
接触:
- Study Coordinator
- 电话号码:+555133396039
-
-
Santa Catarina
-
Lages、Santa Catarina、巴西、88501-001
- 招聘中
- ANIMI - Unidade de Tratamento Oncologico ( Site 0421)
-
接触:
- Study Coordinator
- 电话号码:+554933805200
-
-
São Paulo
-
São José do Rio Preto、São Paulo、巴西、15090-000
- 招聘中
- Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0414)
-
接触:
- Study Coordinator
- 电话号码:55 17 32015054
-
-
-
-
-
Thessaloniki、希腊、552 36
- 招聘中
- Agios Loukas Clinic ( Site 0702)
-
接触:
- Study Coordinator
- 电话号码:+302310390972
-
-
Attica
-
Athens、Attica、希腊、115 28
- 招聘中
- Alexandra General Hospital of Athens ( Site 0703)
-
接触:
- Study Coordinator
- 电话号码:+302132162543
-
Athens、Attica、希腊、115 28
- 招聘中
- Evgenidion Clinic Agia Trias S.A ( Site 0701)
-
接触:
- Study Coordinator
- 电话号码:+302107286444
-
-
-
-
Hesse
-
Kassel、Hesse、德国、34125
- 招聘中
- Klinikum Kassel GmbH ( Site 1212)
-
接触:
- Study Coordinator
- 电话号码:+4956198017547
-
-
Thuringia
-
Jena、Thuringia、德国、07747
- 招聘中
- Universitätsklinikum Jena ( Site 1211)
-
接触:
- Study Coordinator
- 电话号码:+49 36419329101
-
-
-
-
-
Brescia、意大利、25123
- 招聘中
- Azienda Ospedaliera Spedali Civili di Brescia ( Site 1501)
-
接触:
- Study Coordinator
- 电话号码:+390303998428
-
Lecco、意大利、23900
- 招聘中
- ASST DI LECCO ( Site 1509)
-
接触:
- Study Coordinator
- 电话号码:0039 0341489167
-
Milan、意大利、20141
- 招聘中
- Istituto Europeo di Oncologia ( Site 1503)
-
接触:
- Study Coordinator
- 电话号码:390257489543
-
Milan、意大利、20133
- 招聘中
- Istituto Nazionale dei Tumori ( Site 1504)
-
接触:
- Study Coordinator
- 电话号码:+390223903619
-
Padova、意大利、35128
- 招聘中
- Istituto Oncologico Veneto ( Site 1506)
-
接触:
- Study Coordinator
- 电话号码:0039 0498215729
-
Roma、意大利、00168
- 招聘中
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1510)
-
接触:
- Study Coordinator
- 电话号码:+390630157004
-
Torino、意大利、10128
- 招聘中
- Ospedale Mauriziano ( Site 1507)
-
接触:
- Study Coordinator
- 电话号码:0039 0115082764
-
-
-
-
-
Oslo、挪威、0424
- 招聘中
- Oslo University Hospital ( Site 2001)
-
接触:
- Study Coordinator
- 电话号码:+47-48512384
-
-
Rogaland
-
Stavanger、Rogaland、挪威、4068
- 招聘中
- Stavanger Universitetssjukehus ( Site 2002)
-
接触:
- Study Coordinator
- 电话号码:4751518000
-
-
Vest-Agder
-
Kristiansand、Vest-Agder、挪威、4615
- 招聘中
- Sorlandet Sykehus Kristiansand ( Site 2003)
-
接触:
- Study Coordinator
- 电话号码:+4738073070
-
-
-
-
-
Hradec Králové、捷克语、500 05
- 招聘中
- Fakultni nemocnice Hradec Kralove ( Site 3307)
-
接触:
- Study Coordinator
- 电话号码:+420 495 831 111
-
Prague、捷克语、128 08
- 招聘中
- Vseobecna fakultni nemocnice v Praze ( Site 3305)
-
接触:
- Study Coordinator
- 电话号码:+420224967451
-
Prague、捷克语、100 34
- 招聘中
- Fakultni nemocnice Kralovske Vinohrady ( Site 3306)
-
接触:
- Study Coordinator
- 电话号码:+420267161111
-
Prague、捷克语、150 06
- 招聘中
- Fakultní nemocnice Motol a Homolka ( Site 3302)
-
接触:
- Study Coordinator
- 电话号码:+420224431111
-
-
Brno-mesto
-
Brno、Brno-mesto、捷克语、602 00
- 招聘中
- Fakultni Nemocnice Brno Bohunice ( Site 3304)
-
接触:
- Study Coordinator
- 电话号码:420532233843
-
-
Ostrava Mesto
-
Ostrava-Poruba、Ostrava Mesto、捷克语、708 52
- 招聘中
- Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 3303)
-
接触:
- Study Coordinator
- 电话号码:+420597371804
-
-
-
-
-
Fukuoka、日本、811-1395
- 招聘中
- National Hospital Organization Kyushu Cancer Center ( Site 1603)
-
接触:
- Study Coordinator
- 电话号码:+81-92-541-3231
-
Kagoshima、日本、890-8760
- 招聘中
- Kagoshima City Hospital ( Site 1613)
-
接触:
- Study Coordinator
- 电话号码:+81-99-230-7000
-
Niigata、日本、951-8566
- 招聘中
- Niigata Cancer Center Hospital ( Site 1608)
-
接触:
- Study Coordinator
- 电话号码:+81-25-266-5111
-
Okayama、日本、700-8558
- 招聘中
- Okayama University Hospital ( Site 1619)
-
接触:
- Study Coordinator
- 电话号码:+81-86-223-7151
-
Osaka、日本、541-8567
- 招聘中
- Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1604)
-
接触:
- Study Coordinator
- 电话号码:+81-6-6945-1181
-
-
Aichi-ken
-
Nagoya、Aichi-ken、日本、464-8681
- 招聘中
- Aichi Cancer Center ( Site 1601)
-
接触:
- Study Coordinator
- 电话号码:+81-52-762-6111
-
-
Fukuoka
-
Kurume、Fukuoka、日本、830-0011
- 招聘中
- Kurume University Hospital ( Site 1615)
-
接触:
- Study Coordinator
- 电话号码:+81-942-35-3311
-
-
Gunma
-
Ōta、Gunma、日本、373-8550
- 招聘中
- Gunma Prefectural Cancer Center ( Site 1605)
-
接触:
- Study Coordinator
- 电话号码:+81-276-38-0771
-
-
Hokkaido
-
Sapporo、Hokkaido、日本、060-8648
- 招聘中
- Hokkaido University Hospital ( Site 1609)
-
接触:
- Study Coordinator
- 电话号码:+81-11-716-1161
-
-
Hyōgo
-
Akashi、Hyōgo、日本、673-8558
- 招聘中
- Hyogo Cancer Center ( Site 1620)
-
接触:
- Study Coordinator
- 电话号码:+81-78-929-1151
-
-
Iwate
-
Shiwa-gun、Iwate、日本、028-3695
- 招聘中
- Iwate Medical University Hospital ( Site 1610)
-
接触:
- Study Coordinator
- 电话号码:+81-19-613-7111
-
-
Saitama
-
Hidaka、Saitama、日本、350-1298
- 招聘中
- Saitama Medical University International Medical Center ( Site 1607)
-
接触:
- Study Coordinator
- 电话号码:+81-42-984-4111
-
-
Shizuoka
-
Sunto-gun,、Shizuoka、日本、411-8777
- 招聘中
- Shizuoka Cancer Center ( Site 1618)
-
接触:
- Study Coordinator
- 电话号码:+81-55-989-5222
-
-
Tokyo
-
Koto、Tokyo、日本、135-8550
- 招聘中
- Cancer Institute Hospital of JFCR ( Site 1614)
-
接触:
- Study Coordinator
- 电话号码:+81-3-3520-0111
-
Shinjyuku、Tokyo、日本、160-8582
- 招聘中
- Keio University Hospital ( Site 1611)
-
接触:
- Study Coordinator
- 电话号码:+81-3-3353-1211
-
-
-
-
Los Lagos Region
-
Port Montt、Los Lagos Region、智利、5507642
- 招聘中
- Clinica Puerto Montt ( Site 0606)
-
接触:
- Study Coordinator
- 电话号码:56961687093
-
-
Region M. de Santiago
-
Santiago、Region M. de Santiago、智利、8330073
- 招聘中
- Pontificia Universidad Catolica de Chile ( Site 0602)
-
接触:
- Study Coordinator
- 电话号码:+56934331806
-
Santiago、Region M. de Santiago、智利、7650568
- 招聘中
- Clínica Alemana de Santiago ( Site 0610)
-
接触:
- Study Coordinator
- 电话号码:+56996197211
-
Santiago、Region M. de Santiago、智利、7500921
- 招聘中
- Fundación Arturo López Pérez ( Site 0607)
-
接触:
- Study Coordinator
- 电话号码:56224205098
-
Santiago、Region M. de Santiago、智利、8420383
- 招聘中
- Bradfordhill ( Site 0601)
-
接触:
- Study Coordinator
- 电话号码:+5622949070
-
-
Valparaiso
-
Viña del Mar、Valparaiso、智利、2520598
- 招聘中
- ONCOCENTRO APYS-ACEREY ( Site 0603)
-
接触:
- Study Coordinator
- 电话号码:+56323320850
-
-
-
-
Hainaut
-
Charleroi、Hainaut、比利时、6000
- 招聘中
- Grand Hopital de Charleroi ( Site 0303)
-
接触:
- Study Coordinator
- 电话号码:+3260 11 06 04
-
-
Oost-Vlaanderen
-
Ghent、Oost-Vlaanderen、比利时、9000
- 招聘中
- AZ Maria Middelares ( Site 0302)
-
接触:
- Study Coordinator
- 电话号码:+32 9 246 95 19
-
-
Vlaams-Brabant
-
Leuven、Vlaams-Brabant、比利时、3000
- 招聘中
- UZ Leuven ( Site 0301)
-
接触:
- Study Coordinator
- 电话号码:+32 16 34 74 19
-
-
-
-
Auvergne-Rhône-Alpes
-
Lyon、Auvergne-Rhône-Alpes、法国、69008
- 招聘中
- CENTRE LEON BERARD ( Site 1101)
-
接触:
- Study Coordinator
- 电话号码:+33478782888
-
-
Bas-Rhin
-
Strasbourg、Bas-Rhin、法国、67000
- 招聘中
- Hopitaux Universitaires de Strasbourg ( Site 1109)
-
接触:
- Study Coordinator
- 电话号码:0368767141
-
-
Bouches-du-Rhone
-
Marseille、Bouches-du-Rhone、法国、13273
- 招聘中
- Institut Paoli Calmettes ( Site 1111)
-
接触:
- Study Coordinator
- 电话号码:+33491223333
-
-
Cotes-d Armor
-
Plérin、Cotes-d Armor、法国、22190
- 招聘中
- Hôpital Privé Des Côtes d'Armor ( Site 1102)
-
接触:
- Study Coordinator
- 电话号码:+33296752216
-
-
Finistere
-
Brest、Finistere、法国、29200
- 招聘中
- CHRU de Brest - Hopital de la Cavale Blanche ( Site 1104)
-
接触:
- Study Coordinator
- 电话号码:+33230338161
-
-
Haute-Garonne
-
Toulouse、Haute-Garonne、法国、31059
- 招聘中
- LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1114)
-
接触:
- Study Coordinator
- 电话号码:+33531155101
-
-
Haute-Vienne
-
Limoges、Haute-Vienne、法国、87042
- 招聘中
- Centre Hospitalier Universitaire Dupuytren ( Site 1112)
-
接触:
- Study Coordinator
- 电话号码:+33555056268
-
-
Indre-et-Loire
-
Tours、Indre-et-Loire、法国、37044
- 招聘中
- Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau ( Site 1105)
-
接触:
- Study Coordinator
- 电话号码:+33247478261
-
-
Nord
-
Lille、Nord、法国、59020
- 招聘中
- Centre Oscar Lambret ( Site 1106)
-
接触:
- Study Coordinator
- 电话号码:+33320295606
-
-
Puy-de-Dome
-
Clermont-Ferrand、Puy-de-Dome、法国、63003
- 招聘中
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1113)
-
接触:
- Study Coordinator
- 电话号码:+33473278080
-
-
-
-
Greater Poland Voivodeship
-
Poznan、Greater Poland Voivodeship、波兰、61-866
- 招聘中
- Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie ( Site 2105)
-
接触:
- Study Coordinator
- 电话号码:+48 61 8850 557
-
Poznan、Greater Poland Voivodeship、波兰、60-569
- 招聘中
- Uniwersytecki Szpital Kliniczny w Poznaniu-Oddzial Ginekologii Onkologicznej ( Site 2106)
-
接触:
- Study Coordinator
- 电话号码:+48618549014
-
-
Masovian Voivodeship
-
Siedlce、Masovian Voivodeship、波兰、08-110
- 招聘中
- Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2102)
-
接触:
- Study Coordinator
- 电话号码:+48256403485
-
-
Podlaskie Voivodeship
-
Bialystok、Podlaskie Voivodeship、波兰、15-027
- 招聘中
- Bialostockie Centrum Onkologii ( Site 2104)
-
接触:
- Study Coordinator
- 电话号码:+48856646732
-
-
West Pomeranian Voivodeship
-
Szczecin、West Pomeranian Voivodeship、波兰、70-111
- 招聘中
- Uniwersytecki Szpital Kliniczny nr2 PUM w Szczecinie ( Site 2103)
-
接触:
- Study Coordinator
- 电话号码:+48 91 466 10 00
-
-
-
-
Bangkok
-
Bangkok、Bangkok、泰国、10400
- 招聘中
- Ramathibodi Hospital. ( Site 3402)
-
接触:
- Study Coordinator
- 电话号码:+6622011451
-
Bangkoknoi、Bangkok、泰国、10700
- 招聘中
- Faculty of Medicine Siriraj Hospital ( Site 3401)
-
接触:
- Study Coordinator
- 电话号码:+6624194488
-
-
Changwat Khon Kaen
-
Muang、Changwat Khon Kaen、泰国、40002
- 招聘中
- Faculty of Medicine - Khon Kaen University ( Site 3403)
-
接触:
- Study Coordinator
- 电话号码:+6643348382
-
-
-
-
New South Wales
-
Westmead、New South Wales、澳大利亚、2145
- 招聘中
- Westmead Hospital ( Site 0201)
-
接触:
- Study Coordinator
- 电话号码:0288909518
-
-
Queensland
-
Brisbane、Queensland、澳大利亚、4120
- 招聘中
- Gallipoli Medical Research Ltd ( Site 0204)
-
接触:
- Study Coordinator
- 电话号码:+610733947807
-
-
Victoria
-
East Melbourne、Victoria、澳大利亚、3002
- 招聘中
- Epworth Freemasons ( Site 0207)
-
接触:
- Study Coordinator
- 电话号码:+61385595000
-
-
-
-
-
Cork、爱尔兰、T12 DC4A
- 招聘中
- Cork University Hospital ( Site 1303)
-
接触:
- Study Coordinator
- 电话号码:+350214922000
-
Dublin、爱尔兰、D08 E9P6
- 招聘中
- St James Hospital ( Site 1302)
-
接触:
- Study Coordinator
- 电话号码:+353014103000
-
-
-
-
Stockholm County
-
Stockholm、Stockholm County、瑞典、171 76
- 招聘中
- Karolinska Universitetssjukhuset Solna ( Site 2502)
-
接触:
- Study Coordinator
- 电话号码:+460812370000
-
-
-
-
-
Geneva、瑞士、1205
- 招聘中
- Hôpitaux Universitaires de Genève (HUG) ( Site 3502)
-
接触:
- Study Coordinator
- 电话号码:+41795534976
-
-
Canton Ticino
-
Bellinzona、Canton Ticino、瑞士、6500
- 招聘中
- Ospedale Regionale Bellinzona e Valli ( Site 3501)
-
接触:
- Study Coordinator
- 电话号码:41918118194
-
-
Canton of Bern
-
Bern、Canton of Bern、瑞士、3010
- 招聘中
- Inselspital Bern ( Site 3504)
-
接触:
- Study Coordinator
- 电话号码:41316326416
-
-
Kanton Graubünden
-
Chur、Kanton Graubünden、瑞士、7000
- 招聘中
- Kantonsspital Graubünden ( Site 3503)
-
接触:
- Study Coordinator
- 电话号码:+41 81 256 6646
-
-
-
-
-
Lima、秘鲁、15036
- 招聘中
- IPOR Instituto Peruano de Oncología & Radioterapia ( Site 3604)
-
接触:
- Study Coordinator
- 电话号码:+51 951 881 870
-
Lima、秘鲁、15072
- 招聘中
- Clínica San Felipe ( Site 3603)
-
接触:
- Study Coordinator
- 电话号码:+5112190000 Ext 8327
-
Lima、秘鲁、15102
- 招聘中
- Hospital Cayetano Heredia ( Site 3607)
-
接触:
- Study Coordinator
- 电话号码:+51 953 838 268
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35233
- 招聘中
- University of Alabama - Birmingham ( Site 0058)
-
接触:
- Study Coordinator
- 电话号码:205-934-4986
-
-
California
-
La Jolla、California、美国、92093
- 招聘中
- UCSD Moores Cancer Center ( Site 0038)
-
接触:
- Study Coordinator
- 电话号码:858-822-6100
-
Newport Beach、California、美国、92663
- 招聘中
- Hoag Memorial Hospital Presbyterian ( Site 0074)
-
接触:
- Study Coordinator
- 电话号码:949-764-4577
-
Walnut Creek、California、美国、94598
- 招聘中
- John Muir Health Cancer Center ( Site 0069)
-
接触:
- Study Coordinator
- 电话号码:925-692-5603
-
-
Colorado
-
Aurora、Colorado、美国、80045
- 招聘中
- Anschutz Cancer Pavilion ( Site 0049)
-
接触:
- Study Coordinator
- 电话号码:303-724-2066
-
Highlands Ranch、Colorado、美国、80129
- 招聘中
- University of Colorado Health - Highlands Ranch Hospital ( Site 0094)
-
接触:
- Study Coordinator
- 电话号码:303-724-2066
-
-
Florida
-
Miami Beach、Florida、美国、33140
- 招聘中
- Mount Sinai Cancer Center ( Site 0029)
-
接触:
- Study Coordinator
- 电话号码:305-674-2625
-
Orlando、Florida、美国、32806
- 招聘中
- Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085)
-
接触:
- Study Coordinator
- 电话号码:321-841-8393
-
-
Georgia
-
Atlanta、Georgia、美国、30308
- 招聘中
- Winship Cancer Institute of Emory University ( Site 0037)
-
接触:
- Study Coordinator
- 电话号码:404-778-1900
-
-
Illinois
-
Arlington Heights、Illinois、美国、60005
- 招聘中
- Illinois Cancer Specialists (ICS) ( Site 8009)
-
接触:
- Study Coordinator
- 电话号码:847-259-4482
-
-
Indiana
-
Fort Wayne、Indiana、美国、46845
- 招聘中
- Parkview Research Center at Parkview Regional Medical Center ( Site 0055)
-
接触:
- Study Coordinator
- 电话号码:206-266-7701
-
Indianapolis、Indiana、美国、46237
- 招聘中
- Franciscan Health Indianapolis ( Site 0081)
-
接触:
- Study Coordinator
- 电话号码:317-528-5000
-
-
Louisiana
-
Covington、Louisiana、美国、70433
- 招聘中
- Women's Cancer Care ( Site 0018)
-
接触:
- Study Coordinator
- 电话号码:985-892-2252
-
-
Maine
-
Scarborough、Maine、美国、04074
- 招聘中
- Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0060)
-
接触:
- Study Coordinator
- 电话号码:207-883-0069
-
-
Maryland
-
Columbia、Maryland、美国、21044
- 招聘中
- Maryland Oncology Hematology (MOH) ( Site 8002)
-
接触:
- Study Coordinator
- 电话号码:410-964-2212
-
-
Nebraska
-
Omaha、Nebraska、美国、68114
- 招聘中
- Nebraska Methodist Hospital ( Site 0004)
-
接触:
- Study Coordinator
- 电话号码:402-354-7939
-
Omaha、Nebraska、美国、68198
- 招聘中
- University Of Nebraska Medical Center ( Site 0035)
-
接触:
- Study Coordinator
- 电话号码:402-559-2000
-
-
Nevada
-
Reno、Nevada、美国、89511
- 招聘中
- The Center of Hope ( Site 0025)
-
接触:
- Study Coordinator
- 电话号码:775-327-4673
-
-
New York
-
Albany、New York、美国、12208-1743
- 招聘中
- Womens Cancer Care Associates, LLC ( Site 0023)
-
接触:
- Study Coordinator
- 电话号码:518-458-1390
-
New York、New York、美国、10022
- 招聘中
- Memorial Sloan Kettering Cancer Center ( Site 0072)
-
接触:
- Study Coordinator
- 电话号码:347-923-8746
-
-
North Carolina
-
Durham、North Carolina、美国、27710
- 招聘中
- Duke Cancer Center ( Site 0012)
-
接触:
- Study Coordinator
- 电话号码:919-681-6900
-
-
Ohio
-
Cincinnati、Ohio、美国、45219
- 招聘中
- University of Cincinnati Medical Center ( Site 0042)
-
接触:
- Study Coordinator
- 电话号码:513-584-1000
-
Hilliard、Ohio、美国、43026
- 招聘中
- The Ohio State University ( Site 0005)
-
接触:
- Study Coordinator
- 电话号码:614-293-3300
-
-
Oklahoma
-
Tulsa、Oklahoma、美国、74146
- 招聘中
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0007)
-
接触:
- Study Coordinator
- 电话号码:918-505-3200
-
-
Oregon
-
Portland、Oregon、美国、97227
- 招聘中
- Kaiser Permanente Interstate Medical Office - Central ( Site 0089)
-
接触:
- Study Coordinator
- 电话号码:503-335-2400
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- 招聘中
- Hospital of the University of Pennsylvania ( Site 0071)
-
接触:
- Study Coordinator
- 电话号码:215-662-4000
-
Pittsburgh、Pennsylvania、美国、15224
- 招聘中
- AHN West Penn Hospital ( Site 0051)
-
接触:
- Study Coordinator
- 电话号码:412-578-4517
-
-
Rhode Island
-
Providence、Rhode Island、美国、02905
- 招聘中
- Women & Infants Hospital ( Site 0001)
-
接触:
- Study Coordinator
- 电话号码:401-274-1122x48181
-
-
Tennessee
-
Germantown、Tennessee、美国、38138
- 招聘中
- West Cancer Center and Research Institute ( Site 0013)
-
接触:
- Study Coordinator
- 电话号码:901-683-0055
-
Knoxville、Tennessee、美国、37920
- 招聘中
- University of Tennessee Medical Center ( Site 0087)
-
接触:
- Study Coordinator
- 电话号码:865-305-9000
-
Nashville、Tennessee、美国、37232
- 招聘中
- Henry-Joyce Cancer Clinic ( Site 0011)
-
接触:
- Study Coordinator
- 电话号码:615-936-4585
-
-
Texas
-
Fort Worth、Texas、美国、76104
- 招聘中
- JPS Health Network ( Site 0084)
-
接触:
- Study Coordinator
- 电话号码:817-702-7001
-
-
Virginia
-
Fairfax、Virginia、美国、22031
- 招聘中
- Virginia Cancer Specialists (VCS) ( Site 8012)
-
接触:
- Study Coordinator
- 电话号码:703-280-5390
-
Norfolk、Virginia、美国、23502
- 招聘中
- Virginia Oncology Associates (VOA) ( Site 8013)
-
接触:
- Study Coordinator
- 电话号码:757-466-8663
-
-
-
-
North Ostrobothnia
-
Oulu、North Ostrobothnia、芬兰、90220
- 招聘中
- Oulun yliopistollinen sairaala ( Site 1003)
-
接触:
- Study Coordinator
- 电话号码:+358 8 3153108
-
-
Northern Savonia
-
Kuopio、Northern Savonia、芬兰、70200
- 招聘中
- Kuopion Yliopistollinen Sairaala ( Site 1004)
-
接触:
- Study Coordinator
- 电话号码:+35844 7176780
-
-
Pirkanmaa
-
Tampere、Pirkanmaa、芬兰、33520
- 招聘中
- Tampereen yliopistollinen sairaala ( Site 1002)
-
接触:
- Study Coordinator
- 电话号码:+358331166203
-
-
Southwest Finland
-
Turku、Southwest Finland、芬兰、20520
- 招聘中
- Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001)
-
接触:
- Study Coordinator
- 电话号码:+358 2 313 0000
-
-
-
-
-
Manchester、英国、m20 4bx
- 招聘中
- The Christie NHS Foundation Trust ( Site 2804)
-
接触:
- Study Coordinator
- 电话号码:0161 918 7690
-
-
Bath And North East Somerset
-
Bath、Bath And North East Somerset、英国、BA1 3NG
- 招聘中
- Royal United Hospital Bath NHS Foundation Trust ( Site 2808)
-
接触:
- Study Coordinator
- 电话号码:+441225821778
-
-
Cambridgeshire
-
Cambridge、Cambridgeshire、英国、CB2 2QQ
- 招聘中
- Addenbrookes Hospital ( Site 2802)
-
接触:
- Study Coordinator
- 电话号码:+441223805000
-
-
Leicestershire
-
Leicester、Leicestershire、英国、LE3 9QP
- 招聘中
- University Hospitals of Leicester NHS Trust ( Site 2805)
-
接触:
- Study Coordinator
- 电话号码:+443003031573
-
-
London, City of
-
London、London, City of、英国、NW1 2PG
- 招聘中
- University College London Hospitals ( Site 2801)
-
接触:
- Study Coordinator
- 电话号码:+4402034477807
-
-
-
-
-
Barcelona、西班牙、08035
- 招聘中
- Hospital Vall D Hebron ( Site 2403)
-
接触:
- Study Coordinator
- 电话号码:+34934894350
-
Barcelona、西班牙、08907
- 招聘中
- ICO L Hospitalet ( Site 2408)
-
接触:
- Study Coordinator
- 电话号码:+34932607744
-
Barcelona、西班牙、08036
- 招聘中
- Hospital Clinic I Provincial de Barcelona ( Site 2409)
-
接触:
- Study Coordinator
- 电话号码:+34932275402
-
Córdoba、西班牙、14004
- 招聘中
- Hospital Universitario Reina Sofia ( Site 2406)
-
接触:
- Study Coordinator
- 电话号码:+34957011456
-
Madrid、西班牙、28034
- 招聘中
- Hospital Ramon y Cajal ( Site 2405)
-
接触:
- Study Coordinator
- 电话号码:+34913368263
-
Madrid、西班牙、28040
- 招聘中
- Hospital Clinico San Carlos... ( Site 2410)
-
接触:
- Study Coordinator
- 电话号码:34913303000 x484811
-
Madrid、西班牙、28046
- 招聘中
- Hospital Universitario La Paz-Oncología Médica ( Site 2404)
-
接触:
- Study Coordinator
- 电话号码:+34679927508
-
-
Gerona
-
Girona、Gerona、西班牙、17007
- 招聘中
- Institut Català d'Oncologia (ICO) - Girona ( Site 2402)
-
接触:
- Study Coordinator
- 电话号码:+34972225834
-
-
La Coruna
-
A Coruña、La Coruna、西班牙、15006
- 招聘中
- Complejo Hospitalario Universitario A Coruna ( Site 2412)
-
接触:
- Study Coordinator
- 电话号码:34981178353
-
-
Madrid, Comunidad de
-
Madrid、Madrid, Comunidad de、西班牙、28027
- 招聘中
- Clinica Universidad de Navarra ( Site 2407)
-
接触:
- Study Coordinator
- 电话号码:+34913531920/ 7513
-
-
Valenciana, Comunitat
-
Valencia、Valenciana, Comunitat、西班牙、46009
- 招聘中
- Instituto Valenciano de Oncologia - IVO ( Site 2411)
-
接触:
- Study Coordinator
- 电话号码:+34961114229
-
-
-
-
-
CABA、阿根廷、C1280AEB
- 招聘中
- Hospital Britanico de Buenos Aires ( Site 2905)
-
接触:
- Study Coordinator
- 电话号码:+5411 4309 4469
-
La Rioja、阿根廷、F5300COE
- 招聘中
- Fundación CORI para la Investigación y Prevención del Cáncer ( Site 2907)
-
接触:
- Study Coordinator
- 电话号码:+54 380 4336443
-
-
Buenos Aires
-
Ciudad Autonoma de Buenos Aires、Buenos Aires、阿根廷、C1119ACN
- 招聘中
- Hospital Aleman ( Site 2903)
-
接触:
- Study Coordinator
- 电话号码:+5491148277000
-
Ciudad Autónoma de Buenos Aires、Buenos Aires、阿根廷、C1426ANZ
- 招聘中
- Instituto Alexander Fleming ( Site 2902)
-
接触:
- Study Coordinator
- 电话号码:5411 3221 8900
-
Mar del Plata、Buenos Aires、阿根廷、B7600FZO
- 招聘中
- Instituto de Investigaciones Clinicas Mar del Plata ( Site 2901)
-
接触:
- Study Coordinator
- 电话号码:+54 223 496 3224
-
-
Buenos Aires F.D.
-
Buenos Aires、Buenos Aires F.D.、阿根廷、C1426AAL
- 招聘中
- Fundación Respirar ( Site 2912)
-
接触:
- Study Coordinator
- 电话号码:+541147815331
-
-
Santa Fe Province
-
Rosario、Santa Fe Province、阿根廷、S2000DVC
- 招聘中
- Sanatorio Parque - Oncología ( Site 2911)
-
接触:
- Study Coordinator
- 电话号码:+543412987413
-
Rosario、Santa Fe Province、阿根廷、S2000KZE
- 招聘中
- Instituto de Oncologia de Rosario ( Site 2909)
-
接触:
- Study Coordinator
- 电话号码:+543414218909
-
-
-
-
-
Seoul、韩国、03080
- 招聘中
- Seoul National University Hospital ( Site 2301)
-
接触:
- Study Coordinator
- 电话号码:+82260724984
-
Seoul、韩国、06351
- 招聘中
- Samsung Medical Center ( Site 2303)
-
接触:
- Study Coordinator
- 电话号码:+82234101382
-
Seoul、韩国、05505
- 招聘中
- Asan Medical Center ( Site 2305)
-
接触:
- Study Coordinator
- 电话号码:+82230103640
-
-
Seoul
-
Seodaemun-Gu、Seoul、韩国、03722
- 招聘中
- Severance Hospital ( Site 2302)
-
接触:
- Study Coordinator
- 电话号码:+82222277969
-
-
Taegu-Kwangyokshi
-
Daegu、Taegu-Kwangyokshi、韩国、42601
- 招聘中
- Keimyung University Dongsan Hospital ( Site 2304)
-
接触:
- Study Coordinator
- 电话号码:+82532586671
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
The main inclusion criteria include but are not limited to the following:
- Has diagnosis of FIGO 2014 Stage III or Stage IV, histologically confirmed epithelial ovarian, primary peritoneal, or fallopian tube carcinoma with one of the following histologies: high-grade serous, high-grade endometrioid, clear cell carcinoma, or malignant mixed Müllerian tumour with a high-grade serous component. Tumors reported as Grade 2 may be enrolled only if predominately (>50%) Grade 3 features are present.
- Has completed primary debulking surgery or interval debulking surgery.
- Has completed first-line (1L) platinum-based chemotherapy, with a response of stable disease, partial response, complete response or no evidence of disease per protocol.
- Has provided tumor tissue that is not previously irradiated.
- Has well-controlled human immunodeficiency virus (HIV) on antiretroviral therapy if diagnosed with HIV
- Has undetectable hepatitis B virus (HBV) viral load and received HBV antiviral therapy if hepatitis B surface antigen (HBsAg)-positive.
- Has undetectable hepatitis C virus (HCV) viral load if has a history of HCV infection.
The main exclusion criteria include but are not limited to the following:
- Has nonepithelial cancers, low-grade serous tumors, low-grade endometrioid tumors, borderline tumors mucinous, seromucinous that is predominantly mucinous, malignant Brenner's tumor, and undifferentiated carcinoma.
- Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
- Has a history of severe eye disease.
- Has active inflammatory bowel disease requiring immunosuppressive medication or a previous history of inflammatory bowel disease.
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease.
- Has a history of (noninfectious) pneumonitis/interstitial lung disease (ILD), which required steroids, has current pneumonitis/ILD, or has suspected ILD, or pneumonitis that cannot be ruled out by standard diagnostic assessments at Screening.
- Received prior systemic anticancer therapy, with the exception of the first-line platinum-based chemotherapy required by the inclusion criteria.
- Had a live or live-attenuated vaccine within 30 days of randomization.
- Has a known additional malignancy that is progressing or required active treatment within the past 3 years.
- Has active infection requiring systemic therapy.
- Has concurrent and active HBV and HCV infections.
- Has HIV infection and a history of Kaposi's sarcoma and/or multicentric Castleman's disease.
- Has not recovered from major surgery or has ongoing surgical complications.
- Has a homologous recombination deficiency (HRD)-positive, unknown, or inconclusive tumor status as determined by the central laboratory.
- Active or ongoing stomatitis of any grade.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Sac-TMT +/- Bevacizumab
Participants will receive sac-TMT on days 1, 15, and 29 (q2W) of every 6-week cycle, until disease progression, prohibitive toxicity, or other protocol-defined reason for discontinuation. Participants receive optional bevacizumab at investigator's discretion on Days 1 and 22 (q3w) of every 6-week cycle, for up to 22 courses. |
Administered via intravenous (IV) infusion at a dose of 4mg/kg
其他名称:
Administered via IV infusion at a dose of 15mg/kg
其他名称:
Participants must receive prophylactic steroid mouthwash (dexamethasone or equivalent). It is recommended that participants receive the following rescue medications prior to sac-TMT infusion, per approved product label: histamine-1 receptor antagonist, histamine-2 receptor antagonist, acetaminophen or equivalent, and dexamethasone or equivalent. |
|
有源比较器:Standard of Care
Participants will either receive bevacizumab q3w of every 6-week cycle for up to 22 courses until disease progression, prohibitive toxicity, or other protocol-defined reason for discontinuation of study intervention, or will be observed only and actively followed if not receiving bevacizumab. |
Administered via IV infusion at a dose of 15mg/kg
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Progression-Free Survival (PFS)
大体时间:Up to approximately 49 months
|
PFS is defined as the time from randomization to the first documented progressive disease (PD) per Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 by blinded independent central review (BICR) or death due to any cause, whichever occurs first. Per RECIST 1.1, PD is defined as ≥20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also have demonstrated an absolute increase of ≥5 mm. The appearance of one or more new lesions is also considered PD. |
Up to approximately 49 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall Survival (OS)
大体时间:Up to approximately 78 months
|
OS is defined as the time from randomization to death due to any cause. |
Up to approximately 78 months
|
|
Progression-Free Survival 2 (PFS2)
大体时间:Up to approximately 78 months
|
PFS2 as assessed by investigator is defined as the time from randomization to the documented subsequent objective disease progression after initiation of new anticancer therapy or death due to any cause, whichever occurs first. |
Up to approximately 78 months
|
|
Number of Participants Who Experience an Adverse Event (AE)
大体时间:Up to approximately 78 months
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. |
Up to approximately 78 months
|
|
Number of Participants Who Discontinue Study Treatment Due to an AE
大体时间:Up to approximately 78 months
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. |
Up to approximately 78 months
|
|
Change From Baseline in Global Health Status/Quality of Life (GHS/QoL) Combined Score (Items 29 and 30) Using the European Organisation for Research and Treatment of Cancer QoL Questionnaire-Core 30 (EORTC QLQ-C30)
大体时间:Baseline and up to approximately 78 months
|
EORTC QLQ-C30 is a questionnaire to assess the overall quality of life (QoL) of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7- point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. A higher score indicates a better overall health status. The change from baseline in EORTC QLQ-C30 Items 29 and 30 combined score will be presented. |
Baseline and up to approximately 78 months
|
|
Change From Baseline in Physical Functioning Combined Score (Items 1 to 5) Using EORTC QLQ-C30
大体时间:Baseline and up to approximately 78 months
|
EORTC QLQ-C30 is a questionnaire to assess the overall QoL of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1 = Not at All to 4 = Very Much). The combined score is computed by averaging the raw scores of the 5 questions and then applying a linear transformation to standardize the average score, so that the combined score ranges from 0 to 100. A higher score indicates a better outcome. The change from baseline in the EORTC QLQ-C30 physical functioning combined score will be presented. |
Baseline and up to approximately 78 months
|
|
Change From Baseline in Role Functioning Combined Score (Items 6 and 7) Using EORTC QLQ-C30
大体时间:Baseline and up to approximately 78 months
|
EORTC QLQ-C30 is a questionnaire to assess the overall QoL of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1 = Not at All to 4 = Very Much). The combined score is computed by averaging the raw scores of the 2 items and then applying a linear transformation to standardize the average score, so that the combined score ranges from 0 to 100. A higher score indicates a better outcome. The change from baseline in the EORTC QLQ-C30 role functioning combined score will be presented. |
Baseline and up to approximately 78 months
|
|
Change From Baseline in Abdominal/Gastrointestinal (GI) Symptoms Combined Score Using the EORTC QLQ-Ovarian Cancer Module 28 (OV28)
大体时间:Baseline and up to approximately 78 months
|
EORTC QLQ-OV28 is an OC-specific module to supplement the EORTC QLQ-C30. Participant responses to the 6 abdominal/GI symptoms scale questions are scored on a 4-point scale (1=not at all, 4=very much). The combined score is computed by averaging the raw scores of the 6 items and then applying a linear transformation to standardize the average score, so that the combined score ranges from 0 to 100. The change from baseline in abdominal and gastrointestinal symptoms (EORTC QLQ-OC28 Items 31-36) score will be presented. A lower score indicates a better outcome. |
Baseline and up to approximately 78 months
|
合作者和调查者
调查人员
- 研究主任:Medical Director、Merck Sharp & Dohme LLC
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2870-021
- MK-2870-021 (其他标识符:MSD)
- GOG-3102 (其他标识符:Gynecologic Oncology Group)
- ENGOT-ov85 (其他标识符:European Network for Gynaecological Oncological Trial groups)
- U1111-1297-5158 (注册表标识符:WHO/UTN)
- 2023-508047-40-00 (注册表标识符:EU CT)
- jRCT2031250647 (注册表标识符:Japan Registry of Clinical Trial (jRCT))
- 2023 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.